| Serial Number | 87699921 |
| Word Mark | Z ZACOL NMX |
| Filing Date | Tuesday, November 28, 2017 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Wednesday, May 8, 2019 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Indication of Colors claimed | The color(s) The colors teal, light green, light blue and dark blue and white are claimed as a feature of the mark is/are claimed as a feature of the mark. |
| Description of Mark | The mark consists of the letter "Z" in a stylized font centered within a circle where the color teal transitions first to light blue, then back to teal, and finally to the color light green from left to right with a vertical light green line to the right, followed by the term "ZACOL" in dark blue font with the subscripted letters "NMX" in teal font. |
| Goods and Services | Medicines for intestinal disorders; pharmaceutical preparations for use in gastroenterology, for the prevention and treatment of diarrhea, antibiotic-associated diarrhea, travellers' diarrhea, for colon and digestive system health and regulation, for improving energy levels, and for maintaining and improving mucous levels and the mucosal lining of the intestines and colon; pharmaceutical preparations for use in sanitary preparations for medical purposes, namely, nutraceutical preparations for colon and digestive system health and regulation, for maintenance and improvement of energy levels, and for maintaining and improving mucous levels and the mucosal lining of the intestines and colon; pharmaceutical preparations for stimulating the growth of intestinal flora, restoring energy and metabolism of the colocyte and rescuing of the colonic mucosal trophism; pharmaceutical preparations for the treatment of colon disorders; pharmaceutical preparations for improving epithelial vitality and repair; pharmaceutical preparations for the prevention or treatment of cancer; pharmaceutical preparations for the prevention or treatment of colorectal cancer; pharmaceutical preparations for restoring the metabolic balance; pharmaceutical preparations for improving the trophic conditions of the mucosa; pharmaceutical preparations for regulating human gut homeostasis; pharmaceutical preparations for the treatment of gastro-intestinal disorders; pharmaceutical preparations for the treatment of inflammatory bowel disease, motility and functional disorders of the bowel such as IBS and colorectal tumours; pharmaceutical preparations for the maintenance of colon eubiosis; pharmaceutical preparations for decreasing intestinal inflammation; pharmaceutical preparations for promoting, supporting and maintaining a healthy colon; pharmaceutical preparations for the treatment of colitis, ulcerative colitis, Crohn's disease, radiation colitis, pouchitis, infectious colitis and shigellosis; pharmaceutical preparations for the treatment of polyposis of the colon; pharmaceutical preparations for the treatment of pain; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; pharmaceutical and veterinary preparations in the form of tablets, capsules, sugar-coated pills, granules, powders or suppositories for use in treating gastrointestinal diseases and conditions; Pharmaceutical preparations, namely, anti-flatulars; sanitary preparations for medical purposes; dietetic foods adapted for medical use; dietetic beverages and food adapted for medical use; pharmaceutical preparations for the treatment of the intestinal infections; pharmaceutical preparations used to treat gastro-intestinal diseases and conditions, diagnostic agents, preparations and substances related to the gastro-intestinal field for medical purposes; medical preparation based on butyric acid and inulin that contributes to the restoration of intestinal barrier; lactic ferments for pharmaceutical use; biological preparations for use in the gastrointestinal diseases and conditions; food supplements; dietary supplements; vitamin supplements; nutritional supplements; dietary supplemental drinks; vitamin preparations in the form of food supplements; nutraceutical products for use as dietary supplements; Nutraceutical preparations for therapeutic or medical purposes; Mineral supplements for human use |
| Goods and Services | Medical apparatus for introducing pharmaceutical preparations, food supplements and nutraceuticals into the human body; Medical apparatus for introducing pharmaceutical preparations, food supplements and nutraceuticals into the colon; Enema apparatus; Enema syringes; Enema apparatus for medical purposes; Medical apparatus for introducing enema preparations into the human body; Injection syringes; Syringes for medical purposes; Surgical devices and instruments; Disposable syringes; Medical device for use in diagnosis and treatment of the gastro-intestinal tract |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 8, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 8, 2017 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Cosmo Technologies, Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 11 - Company |
| Address | Dublin IE |
| Event Date | Event Description |
| Wednesday, May 8, 2019 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Wednesday, May 8, 2019 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, October 10, 2018 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, October 10, 2018 | FINAL REFUSAL E-MAILED |
| Wednesday, October 10, 2018 | FINAL REFUSAL WRITTEN |
| Thursday, September 13, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 13, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, September 13, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 14, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, March 14, 2018 | NON-FINAL ACTION E-MAILED |
| Wednesday, March 14, 2018 | NON-FINAL ACTION WRITTEN |
| Monday, March 12, 2018 | ASSIGNED TO EXAMINER |
| Saturday, December 9, 2017 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, December 8, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, December 1, 2017 | NEW APPLICATION ENTERED IN TRAM |